Trends in onychomycosis prescribing: a single center retrospective study over 15 years
Main Authors: | Yu Wang, Solomon Geizhals, Shari R. Lipner |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-02-01
|
Series: | Journal of Dermatological Treatment |
Online Access: | http://dx.doi.org/10.1080/09546634.2020.1774040 |
Similar Items
-
Retrospective analysis of adverse events with systemic onychomycosis medications reported to the United States Food and Drug Administration
by: Yu Wang, et al.
Published: (2021-10-01) -
Risk Factors and Treatment Trends for Onychomycosis: A Case–Control Study of Onychomycosis Patients in the All of Us Research Program
by: Samantha Jo Albucker, et al.
Published: (2023-06-01) -
Combination Therapy Should Be Reserved as Second-Line Treatment of Onychomycosis: A Systematic Review of Onychomycosis Clinical Trials
by: Julianne M. Falotico, et al.
Published: (2022-03-01) -
Efinaconazole in the treatment of onychomycosis
by: Lipner SR, et al.
Published: (2015-06-01) -
Updated Perspectives on the Diagnosis and Management of Onychomycosis
by: Falotico JM, et al.
Published: (2022-09-01)